In this issue:
Epcoritamab in R/R B-cell NHL
ctDNA monitoring for relapse detection after axicabtagene ciloleucel
Venetoclax + FLAG-Ida in AML
TP53-mutated AML +/– venetoclax
CAR T-cell therapy for CNS R/R ALL
Ibrutinib + lenalidomide and EPOCH-R in R/R DLBCL
Rituximab + gemcitabine and oxaliplatin in R/R DLBCL
Zanubrutinib for CLL and del17p
Autologous EBV-specific T cells for extranodal NK/T lymphoma
Venetoclax + rituximab for relapsed CLL
Please login below to download this issue (PDF)